What is Theator?
Founded in 2018 and headquartered in Palo Alto, California, Theator is a Surgical Intelligence revolution platform built by surgeons for surgeons. Its core mission is to address the inherent variability and disparity in surgical care by leveraging advanced technology. Theator collaborates with leading surgeons, hospitals, professional societies, and research institutions to foster a more transparent and intelligent operating room environment. By empowering surgeons with data-driven insights, the platform aims to elevate surgical expertise and improve patient outcomes. The company's focus on innovation positions it as a key player in the health-tech sector, driving the digital transformation of surgical practices.
How much funding has Theator raised?
Theator has raised a total of $42.5M across 1 funding round:
Series A
$42.5M
Series A (2022): $42.5M with participation from Blumberg Capital Partners, Mayo Clinic, Blumberg Capital L.L.C, and Insight Partners
Key Investors in Theator
Blumberg Capital Partners
Blumberg Capital Partners is a venture capital firm that typically invests in early-stage technology companies. Their focus often includes software, cybersecurity, and data analytics, aiming to back innovative startups with disruptive potential.
Mayo Clinic
Mayo Clinic is a world-renowned nonprofit academic medical center focused on integrated clinical practice, education, and research. Their investment likely signifies a strategic interest in advancing medical technology and improving patient care through innovative solutions like Theator's platform.
Insight Partners
Insight Partners is a global venture capital and private equity firm that invests in high-growth technology and software companies. They are known for their operational expertise and support in scaling portfolio companies, suggesting a focus on Theator's growth and market penetration.
What's next for Theator?
The substantial enterprise-level capital infusion, including the recent strategic investment, signals a strong validation of Theator's vision and market potential. This financing is anticipated to fuel the company's expansion into new markets, enhance its platform capabilities, and deepen its partnerships within the healthcare ecosystem. Theator is poised to further its impact on surgical care, driving efficiency and standardization through its intelligent solutions. The ongoing commitment from investors suggests a trajectory focused on scaling operations and solidifying its position as a leader in surgical intelligence.
See full Theator company page
